Coronavirus Live Count Map India
remove_red_eye 621 Views
Coronavirus Live Count Map World
#Hematology #Internal Medicine #Oncology
Coronavirus FAQ PDF
The U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as “BR”), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies. Polivy is a novel antibody-drug conjugate, and DLBCL is the most common type of non-Hodgkin lymphoma.
The approval of Polivy provides an alternative option for patients in whom multiple treatments have not worked...(FDA, June 10, 2019)